VAERS reports by lot

Pfizer COVID-19 lot NA0739: VAERS reports

44 VAERS reports list lot NA0739 as a Pfizer COVID-19 vaccine, received between 2025-09-29 and 2026-05-13. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
44
Reports
11%
Marked serious
1
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2122%
Neurological1718%
Cardiac / Cardiovascular1515%
Musculoskeletal1515%
General / Systemic (non-local)1414%
Dermatological (non-injection-site)55%
Gastrointestinal44%
Allergic / Anaphylactic33%
Respiratory33%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
California8
North Carolina4
Ohio3
New York3
Michigan3
Iowa2
Arizona2
Pennsylvania2
New Mexico2
Oregon2
Indiana1
Montana1

Reports by month received

MonthReportsBar
2025-092
2025-1014
2025-118
2025-123
2026-018
2026-023
2026-031
2026-044
2026-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Pfizer COVID-19 lots (A–Z): NA0589 · NA0590 · NA0738 · NA0846 · NA4452 · NA4457

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.